NEW YORK, Nov. 20, 2015 /PRNewswire/ -- The proposed
acquisition of Liberator Medical Holdings Inc. ("LBMH" or the
"Company") by C. R. Bard Inc. ("C. R. Bard") is being
investigated by WeissLaw LLP for possible breaches of fiduciary
duty and other violations of law by the Board of Directors of
LBMH. On November 20, 2015, the
Company announced it had reached a definitive agreement for C. R.
Bard to acquire all outstanding shares of LBMH in a transaction
valued at approximately $181 million.
Under the terms of the agreement, LBMH shareholders will
receive $3.35 in cash for each LBMH
share they own.
WeissLaw is investigating whether LBMH's Board acted to maximize
shareholder value prior to entering into the agreement.
Notably, at least one analyst set a target price of $8.00 per LBMH share, more than double the offer
price. Additionally, the Company has reported record revenues in
fiscal year 2014, announcing year-over-year growths of 14.2% and
11.7% in the first and second quarters respectively.
Given these facts, WeissLaw is investigating whether LBMH's
Board acted in the best interests of LBMH's public shareholders by
actively shopping the Company to maximize shareholder value prior
to entering into the agreement with C. R. Bard. If you own
LBMH shares and would like more information about your rights or
our investigation, or if you have information to share with us,
please contact Joshua Rubin by
telephone at (888) 593-4771 or by email at
stockinfo@weisslawllp.com.
WeissLaw LLP has litigated hundreds of stockholder class and
derivative actions for violations of corporate and fiduciary
duties. We have recovered over a billion dollars for
defrauded clients and obtained important corporate governance
relief in many of these cases. If you have information or
would like legal advice concerning possible corporate wrongdoing
(including insider trading, waste of corporate assets, accounting
fraud, or materially misleading information), consumer fraud
(including false advertising, defective products, or other
deceptive business practices), or anti-trust violations, please
email us at stockinfo@weisslawllp.com or fill out the form
on our website,
http://www.weisslawllp.com/contact/report_fraud/.
Attorney Advertising. Past results do not guarantee a
similar outcome.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/weisslaw-llp-liberator-medical-holdings-inc-acquisition-by-c-r-bard-inc-may-not-be-in-the-best-interest-of-lbmh-shareholders-300182675.html
SOURCE WeissLaw LLP